Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Preisser

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Prostate International|October 25, 2021
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancerFelix Preisser, Felix K-H Chun, Severine Banek, et al.
European Urology Focus|February 4, 2025
Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical ProstatectomyReha-Baris Incesu, Felix Preisser, Raisa S Pompe, et al.
The Journal of Urology|June 24, 2018
Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted BiopsiesSami-Ramzi Leyh-Bannurah, Mykyta Kachanov, Dirk Beyersdorff, et al.
European Urology|October 17, 2016
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical ProstatectomyPhilipp Mandel, Felix Preisser, Markus Graefen, et al.
The World Journal of Men'S Health|April 1, 2019
Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and its Role in Salvage Lymph Node DissectionMarieke J Krimphove, Lena H Theissen, Alexander P Cole, et al.
Urologic Oncology|April 5, 2020
Validation of the updated eighth edition of AJCC for prostate cancer: Removal of pT2 substages - Does extent of tumor involvement matter?Raisa S Pompe, Tim Neumann, Lennart Kühnke, et al.
European Urology|February 18, 2019
Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic OutcomesFelix Preisser, Felix K H Chun, Raisa S Pompe, et al.
World Journal of Urology|March 28, 2018
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomyDerya Tilki, Felix Preisser, Pierre Karakiewicz, et al.
World Journal of Urology|April 3, 2019
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of ageDerya Tilki, Valentin Maurer, Raisa S Pompe, et al.
The Canadian Journal of Urology|August 21, 2018
Use of the AccuVein AV400 during RARP: an infrared augmented reality device to help reduce abdominal wall hematomaKyle W Law, Khaled Ajib, Felix Couture, et al.
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Prostate International|October 25, 2021
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancerFelix Preisser, Felix K-H Chun, Severine Banek, et al.
European Urology Focus|February 4, 2025
Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical ProstatectomyReha-Baris Incesu, Felix Preisser, Raisa S Pompe, et al.
The Journal of Urology|June 24, 2018
Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted BiopsiesSami-Ramzi Leyh-Bannurah, Mykyta Kachanov, Dirk Beyersdorff, et al.
European Urology|October 17, 2016
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical ProstatectomyPhilipp Mandel, Felix Preisser, Markus Graefen, et al.
The World Journal of Men'S Health|April 1, 2019
Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and its Role in Salvage Lymph Node DissectionMarieke J Krimphove, Lena H Theissen, Alexander P Cole, et al.
Urologic Oncology|April 5, 2020
Validation of the updated eighth edition of AJCC for prostate cancer: Removal of pT2 substages - Does extent of tumor involvement matter?Raisa S Pompe, Tim Neumann, Lennart Kühnke, et al.
European Urology|February 18, 2019
Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic OutcomesFelix Preisser, Felix K H Chun, Raisa S Pompe, et al.
World Journal of Urology|March 28, 2018
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomyDerya Tilki, Felix Preisser, Pierre Karakiewicz, et al.
World Journal of Urology|April 3, 2019
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of ageDerya Tilki, Valentin Maurer, Raisa S Pompe, et al.
The Canadian Journal of Urology|August 21, 2018
Use of the AccuVein AV400 during RARP: an infrared augmented reality device to help reduce abdominal wall hematomaKyle W Law, Khaled Ajib, Felix Couture, et al.
Pageof 17